| Terra Innovatum Provides Update on Annual Report Filing Process |
Globe Newswire |
04/17 |
18:26 |
| ALDX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Aldeyra Therapeutics Investors - Contact Kirby McInerney LLP by May 29, 2026 |
Globe Newswire |
04/17 |
18:00 |
| Fyresite Reaches New Heights With Shopify Premier Partner Promotion |
Globe Newswire |
04/17 |
17:58 |
| Fyresite Reaches New Heights With Shopify Premier Partner Promotion |
Globe Newswire |
04/17 |
17:58 |
| Fervo Energy Publicly Announces Filing of Registration Statement for Proposed Initial Public Offering |
Globe Newswire |
04/17 |
17:49 |
| Flixy Smart TV Stick Claims Evaluated: The Most Recommended TV Streaming Stick Device Without Costly Subscriptions |
Globe Newswire |
04/17 |
17:46 |
| Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025 |
Globe Newswire |
04/17 |
17:30 |
| Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency |
Globe Newswire |
04/17 |
17:20 |
| ZSPC Investor News: If You Have Suffered Losses in zSpace Inc. (NASDAQ: ZSPC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
04/17 |
17:19 |
| Rocket Doctor Amends 45 Degree Agreement |
Globe Newswire |
04/17 |
17:18 |
| Sow Good Inc. Announces Reverse Stock Split |
Globe Newswire |
04/17 |
17:07 |
| Keeps Hair Growth Product Claims Evaluated: Topical & Oral RX Hair Loss Prescription Treatment with Finasteride, Dutasteride & Minoxidil |
Globe Newswire |
04/17 |
17:01 |
| Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC |
Globe Newswire |
04/17 |
17:00 |
| Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:49 |
| Japan Smaller Capitalization Fund, Inc. Announces Board Determination to Proceed with Conditional Tender Offer |
Globe Newswire |
04/17 |
16:45 |
| Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing |
Globe Newswire |
04/17 |
16:35 |
| ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules |
Globe Newswire |
04/17 |
16:05 |
| ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting |
Globe Newswire |
04/17 |
16:05 |
| SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders |
Globe Newswire |
04/17 |
16:05 |
| Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 |
Globe Newswire |
04/17 |
16:05 |
| QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option |
Globe Newswire |
04/17 |
16:05 |
| VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE |
Globe Newswire |
04/17 |
16:03 |
| Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares |
Globe Newswire |
04/17 |
16:02 |
| Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types |
Globe Newswire |
04/17 |
16:01 |
| Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:01 |
